Furthermore, neurofilament light chain (NfL), an indicator of axonal injury, is elevated in AD and other neurodegenerative states, and emerging evidence suggests glial fibrillary acidic protein (GFAP), a marker of astrocyte activation, is also elevated in AD.19 Here, NEFL is linked to Alzheimer disease.